Prostate Carcinoma Tissue Proteomics for Biomarker Discovery

Cancer

Volumn 98, Issue 12, 2003, Pages 2576-2582

  Zheng, Yaxin ^a   Xu, Ye ^a   Ye, Bin ^a   Lei, Junyi ^a   Weinstein, Michael H ^a   O'Leary, Michael P ^a   Richie, Jerome P ^a   Mok, Samuel C ^a   Liu, Brian C S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Mass spectrometry; Prostate carcinoma; Proteomics; Surface enhanced laser desorption ionization time of flight

Indexed keywords

BIOLOGICAL MARKER; PCA 24 PROTEIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ANALYTICAL EQUIPMENT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DRUG TARGETING; EARLY DIAGNOSIS; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; MALE; MASS SPECTROMETRY; MOLECULAR SIZE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; AGED; HUMANS; LASERS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEINS; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 0344236284     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11849     Document Type: Article

References (20)

1. Jemal A, Murray T, Samuels A, Ghafoar A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5-26.
2. Brawer MK. Prostate-specific antigen: current status. CA Cancer J Clin. 1999;49:264-282.
3. Dhanasekaran SM, Barrette TR, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature. 2001;412:822-826.
4. Singh D, Febbo PG, Ross K, et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell. 2002;1:203-209.
5. Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis. 1997;18:533-537.
6. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science. 1996;274:998-1001.
7. Bonner RF, Emmert-Buck MR, Cole KA, et al. Laser capture microdissection: molecular analysis of tissue. Science. 1997;278:1481-1483.
8. Liu BC, LaRose I, Weinstein LJ, Ahn M, Weinstein MH, Richie JP. Expression of telomerase subunits in normal and neoplastic prostate epithelial cells isolated by laser capture microdissection. Cancer. 2001;92:1943-1948.
9. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011-2015.
10. Kavaler E, Landman J, Chang Y, Droller MJ, Liu BC. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Cancer. 1998;82:708-714.
11. Weinberger SR, Dalmasso EA, Fung ET. Current achievements using ProteinChip Array technology. Curr Opin Chem Biol. 2001;6:86-91.
12. Paweletz CP, Gillespie JW, Ornstein DK, et al. Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip. Drug Dev Res. 2000;49:34-42.
13. Adam BL, Vlahou A, Semmes OJ, Wright GL Jr. Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics. 2001;1:1264-1270.
14. Wang S, Diamond DL, Hass GM, Sokoloff R, Vessella RL. Identification of prostate specific membrane antigen (PSMA) as the target of monoclonal antibody 107-1A4 by ProteinChip Array, surface-enhanced laser desorption/ionization (SELDI). Int J Cancer. 2001;92:871-876.
15. Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M, Kubota Y. Telomerase activity in primary prostate cancer. J Urol. 1997;157:1161-1165.
16. Takahashi C, Miyagawa I, Kumano S, Oshimura M. Detection of telomerase activity in prostate cancer by needle biopsy. Eur Urol. 1997;32:494-498.
17. Orlando C, Gelmini S, Selli C, Pazzagli M. Telomerase in urological malignancy. J Urol. 2001;166:666-673.
18. Swiss Institute of Bioinformatics. TagIdent tool [database online]. Available from URL: http://expasy.ch/tools/tagident.html [accessed 10 May 2003].
19. Petricoin EF III, Ornstein DK, Paweletz CP, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst. 2002;94:1576-1578.
20. Qu Y, Adam BL, Yasui Y, et al. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin Chem. 2002;48:1835-1843.